c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.

被引：0
|
作者：
Tsuta, K. [1 ]
Yoshida, A. [1 ]
Tsuda, H. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1812
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [41] Palliative resections in patients with non-small cell lung cancers. Burden or benefit?
    Striessnig, Anneliese
    Gschwandtner, Elisabeth
    Zettl, Richard
    Lindenmann, Joerg
    Fink-Neuboeck, Nicole
    Fediuk, Melanie
    Maier, Alfred
    Smolle-Juettner, Freyja-Maria
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (19-20) : 775 - 775
  • [42] Metronomic weekly paclitaxel in metastatic or recurrent non-small cell lung cancers.
    Tandon, Nidhi
    Noronha, Vanita
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Prevalence of MET amplification, MET expression, and MET-related genomic alterations in non-small cell lung cancer (NSCLC)
    Ang, A. L.
    Yang, H.
    Anderson, A. A.
    Tang, R.
    Damore, M. A.
    Loberg, R. D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 161 - 162
  • [44] Priming PD-L1 expression by chemotherapeutic agents in non-small cell lung cancers.
    Lin, Emily Pei-Ying
    Yang, Ching-Yao
    Lin, Ching-Wen
    Huang, Bo-Tsang
    Lai, Wei-Yun
    Tseng, Yi-Ting
    Yang, Pan-Chyr
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
    LP Stabile
    JS Lyker
    L Huang
    JM Siegfried
    Gene Therapy, 2004, 11 : 325 - 335
  • [46] Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Harrington, Kymberly
    Arasi, Kavin
    Bertram, Ceyda
    Nowak, Andrew
    Lin, Leo
    Sheu, Bonnie
    Palani, Sunil
    Puri, Neelu
    CANCER RESEARCH, 2015, 75
  • [47] Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
    Stabile, LP
    Lyker, JS
    Huang, L
    Siegfried, JM
    GENE THERAPY, 2004, 11 (03) : 325 - 335
  • [48] c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer.
    Heist, Rebecca Suk
    Motwani, Monica
    Barlesi, Fabrice
    Goldman, Jonathan Wade
    Kelly, Karen
    Sun, Yan
    Wu, Jun
    Bach, Bruce Allen
    Camidge, D. Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Yiming
    Xiao, Xiangtian
    Han, Yuelin
    Xia, Shu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [50] METRIX: International real-world study of c-Met protein overexpression in patients with non-small cell lung cancer
    Horinouchi, H.
    Xu, Z.
    Prince, S. Savic
    De la Iglesia, P.
    Enrico, D. H.
    Desmeules, P.
    Koslucher, A.
    Ansell, P. J.
    Thiebaut, R.
    Hader, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1643 - S1644
12345